Search
for
Sort by
Research 31–60 of 1000+
- A 14-Year-Old Boy with Lower Extremity Swelling and Petechial Rash
- Fever, Maculopapular Rash and Severe Aphthous Stomatitis in a Renal Transplant Patient
- Approaching Sexual Dysfunction, Hair Loss, and Rashes With Lithium
- Acute Encephalomyelitis Syndromes Associated with H1N1 Influenza Vaccinations; Erythema Multiforme Secondary to H1N1 Vaccine; Cytolytic Hepatitis Possibly Related to Oral Contraceptives; Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Associated with Lamotrigine: First Report; Behavioral Disinhibition with Baclofen; Minoxidil-Induced Trichostasis Spinulosa of Terminal Hair; Delayed-Onset Mirtazapine-Related Leukopenia
- Cutaneous signs in COVID ‐19 patients: A review
- Nonmelanoma skin cancer treated with electronic brachytherapy: Results at 1 year
- PD-1+CXCR5−CD4+T cells are correlated with the severity of systemic lupus erythematosus
- Early Clinical Features in Systemic Lupus Erythematosus: Can They Be Used to Achieve Earlier Diagnosis? A Risk Prediction Model
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- Methotrexate for induction of remission in ulcerative colitis
- 9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma
- Gefitinib: an adverse effects profile
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Contact dermatitis to Minoxidil
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Incidence and management of cutaneous toxicities associated with cetuximab
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Cutaneous toxicities of new treatments for melanoma
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Captopril and alopecia: A case report and review of known cutaneous reactions in captopril use
- Eosinophilic Fasciitis Associated With Tryptophan Ingestion
- Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- The use of Minoxidil in the Treatment of Severe Essential Hypertension: A Report on 100 Patients
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Dermatologic Reactions to Targeted Therapy
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III